Evaxion(EVAX) - 2025 Q4 - Earnings Call Transcript

Evaxion Biotech (NasdaqCM:EVAX) Q4 2025 Earnings call March 06, 2026 08:30 AM ET Company ParticipantsBirgitte Rønø - Chief Scientific OfficerHelen Tayton-Martin - CEOThomas Schmidt - CFONone - Managing DirectorConference Call ParticipantsMichael Okunewitch - Senior Biotechnology AnalystTanya Van Hale - AnalystThomas Flaten - Senior Research AnalystOperatorDay, thank you for standing by. Welcome to the Evaxion Business Update and Full Year 2025 Financial Results webcast and conference call. At this time, all ...